Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb;155(3):R137-R145.
doi: 10.1530/REP-17-0619. Epub 2017 Dec 21.

Cell-free fetal DNA and spontaneous preterm birth

Affiliations
Review

Cell-free fetal DNA and spontaneous preterm birth

Sara R van Boeckel et al. Reproduction. 2018 Feb.

Abstract

Inflammation is known to play a key role in preterm and term parturition. Cell-free fetal DNA (cff-DNA) is present in the maternal circulation and increases with gestational age and some pregnancy complications (e.g. preterm birth, preeclampsia). Microbial DNA and adult cell-free DNA can be pro-inflammatory through DNA-sensing mechanisms such as Toll-like receptor 9 and the Stimulator of Interferon Genes (STING) pathway. However, the pro-inflammatory properties of cff-DNA, and the possible effects of this on pregnancy and parturition are unknown. Clinical studies have quantified cff-DNA levels in the maternal circulation in women who deliver preterm and women who deliver at term and show an association between preterm labor and higher cff-DNA levels in the 2nd, 3rd trimester and at onset of preterm birth symptoms. Together with potential pro-inflammatory properties of cff-DNA, this rise suggests a potential mechanistic role in the pathogenesis of spontaneous preterm birth. In this review, we discuss the evidence linking cff-DNA to adverse pregnancy outcomes, including preterm birth, obtained from preclinical and clinical studies.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Figures

Figure 1
Figure 1
DNA sensing through STING and TLR9. (1) DNA enters the cells through a variety of mechanisms, including interactions with C1q, antimicrobial peptides (AMPs) and receptor for advanced glycation end-products (RAGE). (2) This DNA can then be sensed by binding to STING directly or by firstly biding to cyclic GMP-AMP synthase (cGAS). STING activation produces type 1 interferons through transcription factor interferon receptor factor 3 (IRF3) and, to a lesser extent, pro-inflammatory cytokines via activation of NF-κB. (3) TLR9 is found in the endosome and unmethylated DNA (CpG) or DNA with a modified back bone are typical ligands. TLR9 activation produces type 1 interferons and pro-inflammatory cytokines through IRF7 and NF-κB. (4) Pro-inflammatory cytokines are hypothesized to elicit a potent inflammatory response that can lead to the parturition cascade. (5) Type 1 interferons are known to play a role in inflammation and immunomodulation.

References

    1. Barber GN. 2015. STING: infection, inflammation and cancer. Nature Reviews Immunology 15 760–770. (10.1038/nri3921) - DOI - PMC - PubMed
    1. Bauer S. 2006. Toll-erating self DNA. Nature Immunology 7 13–15. (10.1038/nbib106-13) - DOI - PubMed
    1. Bauer M, Hutterer G, Eder M, Majer S, Leshane E, Johnson KL, Peter I, Bianchi DW, Pertl B. 2006. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome. Prenatal Diagnosis 26 831–836. (10.1002/pd.1513) - DOI - PubMed
    1. Bianchi DW. 2004. Circulating fetal DNA: its origin and diagnostic potential-a review. Placenta 25 (Supplement A) S93–S101. (10.1016/j.placenta.2004.01.005) - DOI - PubMed
    1. Birch L, English CA, O’Donoghue K, Barigye O, Fisk NM, Keer JT. 2005. Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clinical Chemistry 51 312–320. (10.1373/clinchem.2004.042713) - DOI - PubMed

Publication types

Substances